MSI High and Low
What does MSI high/low mean? Which has a better prognosis in colon cancer?
Carolyn Vachani, RN, MSN, AOCN, OncoLink Nurse Educator, responds:
Tumors are identified as MSI-H (i.e. MSI-high), meaning they are MMR deficient (dMMR), or MSI-stable and MSI-low, meaning they are considered MMR proficient (pMMR). Studies have found MSI-H tumors are associated with a better prognosis and is present in approximately 22% of stage II colon tumors (but only 12% of stage III tumors). Several studies have found that patients with stage II MSI-H tumors not only did not derive any benefit from 5-FU adjuvant therapy, but they actually fared worse if they were treated. This was not seen for stage III MSI-H tumors. MS-stable disease, however, may benefit from 5-FU based treatment. Some experts recommend testing for MSI testing as another tool to determine the need for treatment in stage II disease.
Learn more: http://www.oncolink.org/types/article.cfm?c=5&s=11&ss=84&id=9621
This question and answer was part of the OncoLink Brown Bag Chat Series. View the entire Interpreting Test Results transcript.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania